Plenco 4304

Product Description

Plenco 4304 was a phenolic molding compound manufactured by Plastics Engineering Company, commonly known as Plenco, a Wisconsin-based plastics manufacturer with a long history of producing thermosetting resin materials for industrial applications. Phenolic molding compounds of this type were developed to meet demanding industrial requirements, offering high heat resistance, dimensional stability, and electrical insulating properties that made them attractive for use across a wide range of manufacturing and industrial environments.

Phenolic compounds — sometimes referred to as phenol-formaldehyde resins or Bakelite-type materials — were among the earliest synthetic plastics adopted by American industry. Products like Plenco 4304 were formulated to be molded under heat and pressure into finished components that would retain their shape and properties even under sustained thermal or mechanical stress. These characteristics made phenolic molding compounds standard materials in the production of electrical components, industrial machinery parts, automotive components, and other applications where durability under demanding conditions was essential.

Plenco’s product lines, including compounds identified by numerical designations such as 4304, were sold to manufacturers and industrial facilities that incorporated them into their own production processes. As a result, exposure to Plenco 4304 was not limited to a single industry but extended broadly across the general industrial workforce — anywhere that phenolic molding compounds were specified, processed, or machined.

Asbestos Content

Certain phenolic molding compounds produced during the mid-twentieth century incorporated asbestos fibers as a functional filler or reinforcing agent. Asbestos was valued in thermosetting resin formulations for several technical reasons: it improved the mechanical strength of the finished molded part, enhanced heat and flame resistance, and helped regulate the flow characteristics of the compound during the molding process. Chrysotile asbestos — the most commercially prevalent form — was the variety most commonly employed in phenolic resin systems, though other fiber types were also used in some formulations.

Litigation records document that Plenco 4304 has been identified as an asbestos-containing phenolic molding compound in the context of personal injury claims brought by workers who alleged occupational exposure. Plaintiffs alleged that the compound, as formulated and sold, contained asbestos fibers that could be released during normal industrial handling, processing, and fabrication activities.

The specific fiber content and formulation details of Plenco 4304 are matters addressed within the litigation record. Documented claims assert that the presence of asbestos in the compound was not adequately disclosed to downstream users or the workers who handled it, and that warnings sufficient to protect workers from the hazards of asbestos inhalation were not provided at the time of sale or use.

How Workers Were Exposed

Industrial workers who handled, processed, or worked in proximity to Plenco 4304 and similar phenolic molding compounds faced potential asbestos exposure through several distinct pathways. Litigation records document that plaintiffs alleged exposure occurring across multiple stages of industrial handling — from the receipt and storage of the raw compound to finished part production and post-molding operations.

Handling of Raw Compound: Phenolic molding compounds were typically supplied in granular, pellet, or powder form. Workers who opened containers, measured, transferred, or loaded raw material into molding equipment could disturb the compound and release airborne dust. If the compound contained asbestos fibers, this dust would carry those fibers into the breathing zone of workers performing these tasks.

Molding Operations: The molding process itself — particularly compression molding, transfer molding, and injection molding operations common in industrial settings — involved exposure to heat and mechanical pressure. While the molding phase partially encapsulated fibers within the finished matrix, pre-heat operations, mold loading, and the handling of flash or excess material around mold parting lines could generate fiber-containing particulate.

Machining and Finishing: Post-molding operations posed a significant exposure risk that litigation records have consistently documented. Plaintiffs alleged that cutting, drilling, grinding, sanding, trimming, and deburring of finished phenolic parts released asbestos fibers in quantities that could be inhaled by workers performing these operations and by bystanders working nearby. Dry machining of phenolic components was particularly hazardous because it generated fine, respirable dust without any suppression of airborne particulate.

Maintenance and Cleanup: Maintenance workers who cleaned molding equipment, removed buildup from mold surfaces, or handled scrap and waste material from phenolic molding operations were also identified as potentially exposed in litigation records. General industrial hygiene practices of earlier decades rarely included respiratory protection adequate to address asbestos fiber exposure during these routine tasks.

Bystander Exposure: Workers who did not directly handle Plenco 4304 but who shared workspaces with those who did — including supervisors, quality control personnel, and workers at adjacent stations — could also have inhaled asbestos fibers that became airborne and migrated through the facility.

Plaintiffs alleged that asbestos-related diseases, including mesothelioma, asbestosis, and lung cancer, developed as a result of this occupational exposure. The latency period for these diseases — often spanning decades between initial exposure and clinical diagnosis — means that workers exposed to Plenco 4304 during its period of industrial use may only now be experiencing the onset of illness.

Plenco 4304 falls within Tier 2 of the legal framework applicable to asbestos product claims, meaning that legal accountability for this product has been pursued through active civil litigation rather than through a pre-established asbestos bankruptcy trust fund. Plastics Engineering Company has not been identified in available public records as a company that established or contributes to an asbestos trust fund of the type administered under Section 524(g) of the U.S. Bankruptcy Code.

Civil Litigation: Litigation records document that personal injury claims involving Plenco 4304 have been filed in asbestos dockets in courts across the United States. Plaintiffs alleged that Plastics Engineering Company was liable for the asbestos-related diseases suffered by workers who were exposed to its phenolic molding compound. Claims have been brought under theories including products liability, failure to warn, negligence, and breach of warranty.

Multi-Defendant Claims: Because phenolic molding compounds were used in industrial facilities alongside many other asbestos-containing materials and equipment, claimants in Plenco 4304 litigation have typically also pursued claims against additional defendants — including manufacturers of other asbestos-containing products present in their workplaces and, in some instances, premises owners. Many of these co-defendants have established asbestos trust funds, and claims against those entities may be filed concurrently with litigation involving Plenco 4304 specifically.

Eligibility Considerations: Workers diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related diseases who can document occupational contact with Plenco 4304 or Plenco phenolic compounds generally should consult with an attorney experienced in asbestos litigation. Establishing product identification, reconstructing workplace exposure history, and coordinating claims across multiple potentially responsible parties are all functions best performed with experienced legal representation.

The statute of limitations for asbestos personal injury claims varies by state and is typically measured from the date of diagnosis rather than the date of exposure. Prompt legal consultation is strongly recommended to preserve all available remedies.